Autoimmunity in lymphoplasmacytoid lymphoma (LPL) and marginal zone lymphoma (MZL)

被引:0
|
作者
Ferrari, S. [1 ]
Tucci, A. [1 ]
Rinaldi, M. [2 ]
Ambrosetti, A. [2 ]
Rossi, G. [1 ]
机构
[1] Spedali Civil Brescia, I-25125 Brescia, Italy
[2] Policlin GB Rossi, Verona, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:228 / 229
页数:2
相关论文
共 50 条
  • [1] Results of upfront therapy for marginal zone lymphoma (MZL).
    Cabanillas, Fernando
    Ortega, Jose Luis
    Rivera-Rodriguez, Noridza
    Rodriguez, Blanca
    Pardo, Wandaly Ibis
    Pavia, Orestes Antonio
    Bruno, Margarita
    Santiago, Karen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Clinic and treatment of different variants of lymphoma of the marginal zone (MZL)
    Lepkov, S.
    Subortceva, I.
    Zeynalova, P.
    Tumyn, G.
    Semenova, A.
    Kokosadze, N.
    Kuprishina, N.
    Kolomiytsev, O.
    Borisovsckay, S.
    Rybuhina, J.
    Kovrigina, A.
    Ettinger, O.
    Zaharov, O.
    Lazarev, I.
    Nikitin, I.
    Ivashenco, R.
    Urvantceva, O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 178 - 179
  • [3] TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
    Clancy, Z.
    Bell, E.
    Chastek, B.
    Bunner, S.
    Copher, R.
    Arekapudi, S.
    VALUE IN HEALTH, 2020, 23 : S41 - S41
  • [4] Lymphoplasmacytoid lymphoma (LPL): An immunophenotypic re-evaluation
    Carlile, B
    McKenna, RW
    Kroft, SH
    LABORATORY INVESTIGATION, 2001, 81 (01) : 157A - 157A
  • [5] Lymphoplasmacytoid lymphoma (LPL): An immunophenotypic re-evaluation
    Carlile, B
    McKenna, RW
    Kroft, SH
    MODERN PATHOLOGY, 2001, 14 (01) : 157A - 157A
  • [6] JS']JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma-2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associated lymphoid tissue], nodal marginal zone lymphoma: NMZL, splenic marginal zone lymphoma: SMZL)
    Yoshida, Isao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
  • [7] TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
    Clancy, Z.
    Bell, E.
    Chastek, B.
    Bunner, S.
    Copher, R.
    Arekapudi, S.
    VALUE IN HEALTH, 2020, 23 : S43 - S43
  • [8] Patient-specific molecular analysis in extranodal marginal zone lymphoma (MZL)
    Bertoni, F
    Roggero, E
    Cavalli, F
    Zucca, E
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S24 - S24
  • [9] Secreted factors determine resistance to idelalisib in splenic marginal zone lymphoma (MZL) models
    Arribas, A. J.
    Napoli, S.
    Cascione, L.
    Sartori, G.
    Gaudio, E.
    Tarantelli, C.
    Mensah, A. A.
    Spriano, F.
    Zucchetto, A.
    Rossi, F. M.
    Rinaldi, A.
    Jovic, S.
    Stathis, A.
    Stussi, G.
    Gattei, V.
    Brown, J. R.
    Esteller, M.
    Zucca, E.
    Rossi, D.
    Bertoni, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S779 - S779
  • [10] Idelalisib monotherapy and durable responses in patients with relapsed or refractory marginal zone lymphoma (MZL)
    Martin, P.
    Armas, A.
    Gopal, A.
    Gyan, E.
    Wagner-Johnston, N.
    Walewski, J.
    Abella, S.
    Ye, W.
    Philip, B.
    Sorenson, B.
    de Vos, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 100 - 100